I need to investigate further but it sounds like EMD have access to a clinical network for potential MDMA treatment but no actual trials in progress. They have designed a trial protocal for a ph 2b study and are currently IP protecting a bunch of MDMA analogues for future treatments.
Some good potential but nothing terribly solid. Of course I might have missed something.
IHL Price at posting:
20.0¢ Sentiment: Buy Disclosure: Held